Navigation Links
Creating a Platform for Managed Care Pull-Through Success in 2011
Date:11/12/2010

CHAPEL HILL, N.C., Nov. 12, 2010 /PRNewswire/ -- In today's payer-driven market, managed care formulary access is critical to a new pharmaceutical product. But achieving access isn't an end unto itself. In addition to formulary placement, a new brand's long-tem commercial success is tied to effective pull-through programs and processes to increase market share after the contract is signed.

To help organizations create and maintain effective pull-through programs and processes, Best Practices, LLC has published a new study, "Developing Managed Care Pull-Through Excellence." This timely research identifies quantitative benchmarks and qualitative insights that will help sales and brand leaders understand how to build an effective pull-through program and leverage Managed Care contracts to generate pharmaceutical product sales.

The term "pull-through" is defined in this study as an integrated process aimed at increasing market share and generating sales for a specific product within a given time frame. Pull-through programs are formal agreements between pharmaceutical companies and managed care accounts that specify product utilization targets, messaging themes and support programs.

This 60-page report captures current pull-through operating tactics and strategies used successfully at 24 companies in the pharmaceutical, biotech and medical device industries.

Topics covered in this report include:

  • How companies establish structures and processes that optimize pull-through. Areas covered include pull-through leadership, planning, training, staff roles, cross-channel and cross-functional collaboration, internal communications processes and tools, use of templates, effectiveness metrics, and trends in budget and staffing levels.
  • Programs and activities that companies use to increase pull-through effectiveness. Contracting strategies,
    '/>"/>

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
2. Creating Partnerships Across R&D and Marketing to Ensure a Successful Global Launch
3. Medco Completes Acquisition of United BioSource Corporation, Creating Powerful Engine for Rapidly Advancing Clinical Insight and Innovation
4. Graymark Healthcare Agrees to Sell Pharmacy Division to Walgreens Creating Pure Play Sleep Apnea Company
5. Empire BlueCross BlueShield Expands Lab Networks -- Creating Broader Choice, Robust Competition and Lower Costs for Consumers
6. Learn How Merck is Creating a Unified Culture and Company Brand During NewsGator Webinar Entitled: From MyMerck to OneMerck - Enterprise 2.0
7. Creating Healthcare Reform from the Inside Out Through Supply Chain Best Practices that Improve Financial and Clinical Performance is Focus of 2010 GHX Supply Chain Summit
8. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
9. CMS Admits New Surety Bond and Accreditation Requirement for Home Medical Equipment Suppliers Creating Patient Access Issues
10. Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates
11. REGISTRAT-MAPI & Trianz Collaborate on Developing Acceliant EDC Platform’s ePRO Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014  Synapse Biomedical Inc. ( www.synapsebiomedical.com ) ... the post-approval study of its NeuRx DPS® System ... meet the FDA enrollment requirement was implanted over ... The NeuRx DPS®, which is the only medical ... patients, is a humanitarian device that obtained approval ...
(Date:9/30/2014)... Sept. 30, 2014  eHealth, electronic access of ... access of this information, has become a major ... that has not translated into user-friendly, effective products. ... - http://photos.prnewswire.com/prnh/20140929/149123 For ... years developing MWD® Health Manager iEHR, a multilingual ...
(Date:9/30/2014)... Sept. 30, 2014 It is evident from the ... is not performing upto expectations due to the lack of ... with the intake of omega-3 fatty acids. Among omega-3 ingredient ... fish oil, attributed to the large vegetarian population in ... polyunsaturated fatty acid (PUFAs) ingredients is in growth stage of ...
Breaking Medicine Technology:Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 2Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients 3MWD Challenges the Big eHealth Players With New Software for Your Smartphone 2Omega-3 Polyunsaturated Fatty Acids (PUFAs) - An Indian Market Overview 2
... The 2009 Frost & Sullivan European Medical ... the radiology applications market is conferred on Viatronix ... the diagnostic imaging space. , (Logo: ... Viatronix has shown dedication to both developing and ...
... PAC, a leading global provider of advanced analytical instruments ... of the ANTEK MultiTek(TM) testing system for the fast, ... and halides. Industries include BioFuels, Chemicals, Food & Beverage, ... , "MultiTek(TM) is the only instrument on the ...
Cached Medicine Technology:Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 2Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 3Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year 4New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides 2
(Date:9/30/2014)... 2014 issue of The FASEB Journal ... a simple blood test. This test, called the "lymphocyte genome ... than ever before, but it may eliminate the need for ... likely to develop cancer in the future. , "The ... peoples, lives," said Diana Anderson, a researcher involved in the ...
(Date:9/30/2014)... HealthDay Reporter MONDAY, Sept. 29, 2014 ... -- artificial valves, hip replacements, surgical mesh and the like ... after their approval by the U.S. Food and Drug Administration, ... prominent nonprofit groups and published online Sept. 29 in ... medical device testing on lax oversight by the FDA. ...
(Date:9/30/2014)... 30, 2014 Edward D. Buckingham, M.D., ... has been approved to be a director of a ... Reconstructive Surgery (AAFPRS) fellowship program. The announcement came last ... Florida. , The Educational and Research Foundation for the ... It represents the finest postgraduate program in the world ...
(Date:9/30/2014)... NC (PRWEB) September 30, 2014 ... and caring individuals, National Children’s Oral Health ... $150,000 in grants to non-profit clinical partners. ... Affiliate Network and deliver comprehensive educational, preventive ... , Recipients include:,     Just ...
(Date:9/30/2014)... TUESDAY, Sept. 30, 2014 (HealthDay News) -- Herceptin is ... cancer called HER2-positive and should remain the standard of ... findings from a long-term clinical trial. HER2-positive breast ... of breast cancer, according to the Mayo Clinic. ... countries received either Herceptin (trastuzumab) or Tykerb (lapatinib) in ...
Breaking Medicine News(10 mins):Health News:New blood test determines whether you have or are likely to get cancer 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 2Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 3Health News:Medical Implant Devices Skate Through Review Process, Studies Claim 4Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 2Health News:Dr. Edward Buckingham Approved to be Fellowship Director for Facial Plastic Surgery 3Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 2Health News:America's ToothFairy Awards More Than $150,000 in Grants to Save Young Smiles 3
... Dr. Jacob Bolotin Awards Presented at 2008 Convention, ... of,the Blind presented $100,000 in cash awards to ... achieving the,full integration of the blind into society ... Bolotin Awards honored ten innovators in the blindness,field ...
... 7 The Peer Group, a leading provider,of ... an,Informed Medical Communications (IMC) company, today announced the ... innovation in moderated,peer influence events whereby two Key ... data, product attributes, and prescribing,experience in a debate-style ...
... of potent, or ,high affinity, antibodies to fight infection. The ... it hinges on a single molecule, a growth factor, without ... do not yet understand about our immune system. In simple ... T cells, which help them. Ways in which these cells ...
... BETHLEHEM, Pa., July 7 MIKE AND IKE(R) Lemonade,Blends(TM) ... candy fans who are members of the facebook(R) community ... To view the Multimedia News Release, go to:, http://www.prnewswire.com/mnr/justborn/33812/ ... Foundation will encourage,their fans who are active on facebook(R) ...
... Corporation (Pink,Sheets: BDRR), a medical imaging and diagnostic ... Network (OTCFN), a division of National,Financial Communications Corp., ... president of OTCFN, said, "In 2007, Bederra generated,revenues ... $471,182, or,approximately $0.01 per share, and has some ...
... Engage Contract Sales Organization And Seek New Marketing ... Partner to Promote Product in UK -, ... DDSS) today announced that it has reacquired the sales and,marketing rights ... Recordati Ireland Ltd. (Recordati). To promote its,product in the UK, the ...
Cached Medicine News:Health News:National Federation of the Blind Awards $100,000 2Health News:The Peer Group Launches Xpert Xchange(SM), an Innovation in Medical Peer Influence Programs 2Health News:Finding suggests novel ways to boost vaccination or natural defenses 2Health News:Photos: MIKE AND IKE(R) Lemonade Blends(TM) and Alex's Lemonade Stand Foundation Join facebook(R) 2Health News:Photos: MIKE AND IKE(R) Lemonade Blends(TM) and Alex's Lemonade Stand Foundation Join facebook(R) 3Health News:Bederra Corporation Retains OTC Financial Network for Investor Relations 2Health News:Bederra Corporation Retains OTC Financial Network for Investor Relations 3Health News:Labopharm Reaquires UK Sales And Marketing Rights to Its Once-Daily Tramadol Product 2
Remote Controlled, Easy to Use,Vision Tester Designed for Screening Children Ages 3 and Older.,Excellent for Pediatric and School Markets....
Contrast Sensitivity is Recognized as a Valuable Tool for Measuring Functional Vision Loss Caused by Early Eye Disease. Distance Test S.W.C.T. 201: Size 27in x 37 in (68.58cm x 93.98cm),Can be Wal...
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking....
Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Medicine Products: